Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
about
BRCA1 is an essential regulator of heart function and survival following myocardial infarctionCardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications.Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular diseaseDiverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Convergence and divergence of genetic and modular networks between diabetes and breast cancer.DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers.Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancerDiabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failureInhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist.Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia.Accelerated geroncogenesis in hereditary breast-ovarian cancer syndromeTriple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsAn Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity.Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers.Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers.Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls.Evaluation of common variants in MG53 and the risk of type 2 diabetes and insulin resistance in Han Chinese.Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy.Adipokines in hereditary breast cancer patients and healthy relatives.Incidence of diabetes among postmenopausal breast cancer survivorsAssociation between tamoxifen treatment and diabetesA Dietary Intervention to Lower Serum Levels of IGF-I in Mutation Carriers
P2860
Q24300290-C321B591-89E5-4D7D-9D7B-EBBF9DB03039Q30487342-D315177D-17EE-4BEA-AFA9-2A86B4BD2F32Q33895047-72978DE3-12EA-40EE-81C3-BFC245803BA3Q34198265-8C1107EB-ED34-4508-9900-EC0E25C005DCQ35571951-04332FCE-395F-4C1F-A26C-DB4879BEA089Q35633272-7D854A19-A9D2-4E78-B23F-121F69CF0C15Q35678104-B6264DA0-CD00-44F4-9B51-9F47A1BE2E0EQ35764308-D988F6D4-A2FD-488A-93C0-C89A2D6D600FQ35886872-3702DE6E-6CBF-4091-923F-13863930E412Q35997957-05864923-7C80-4B65-8750-1CA222BAA3F4Q36519778-378D3B82-7BC8-4067-8674-943E8F2BAF77Q37022075-EAE263EF-8E38-43F0-A07D-CB260028532AQ37525906-E73519CB-936F-4A12-9444-11761C610F5EQ37676233-796A2052-6B5D-424B-842B-B7015CD148FDQ38662947-9D6189B3-E1D9-4619-8E33-D4A7B7EC0D4DQ39003013-CA88C128-17E1-4D04-B8D6-C4DB198FBE8BQ40227381-6253D6B4-D4D7-47BE-AEA5-E2E3AB14E8C1Q40227877-0F27F1FB-CA70-48E4-B90B-24A56B3561F8Q40462939-665858BF-7A8A-45A8-95BC-CC6117A04512Q47129182-CCD52A89-98BF-48E4-AF7E-A1780DC725E2Q57266717-773354CB-D78E-449D-8C2C-9F75F63B7051Q57266723-B01B6FCF-7F3A-4D2A-A2B9-0AC754F64111Q58764289-CCA7411A-0DA3-4652-9A95-09390979599E
P2860
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@ast
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@en
type
label
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@ast
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@en
prefLabel
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@ast
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@en
P2093
P2860
P50
P356
P1433
P1476
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
@en
P2093
Hereditary Breast Cancer Clinical Study Group
Lorraine Lipscombe
Louise Bordeleau
Michael Pollak
Parviz Ghadirian
Peter Ainsworth
P2860
P304
P356
10.1002/CNCR.25595
P407
P577
2010-11-10T00:00:00Z